Business Description
Tectonic Therapeutic Inc
NAICS : 541713
SIC : 2834
ISIN : US8789721086
Description
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 53.32 | |||||
| Equity-to-Asset | 0.89 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.1 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Future 3-5Y EPS without NRI Growth Rate | -25.98 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 70.2 | |||||
| 9-Day RSI | 62.16 | |||||
| 14-Day RSI | 60.22 | |||||
| 6-1 Month Momentum % | 198.76 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 9.39 | |||||
| Quick Ratio | 9.39 | |||||
| Cash Ratio | 9.19 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 0.28 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -38.47 | |||||
| ROA % | -24.09 | |||||
| ROIC % | -251.48 | |||||
| ROC (Joel Greenblatt) % | -476.17 | |||||
| ROCE % | -28.16 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 4.96 | |||||
| Price-to-Tangible-Book | 4.96 | |||||
| EV-to-EBIT | -17.98 | |||||
| EV-to-EBITDA | -18.24 | |||||
| EV-to-FCF | -27.83 | |||||
| Price-to-Net-Current-Asset-Value | 5.17 | |||||
| Price-to-Net-Cash | 5.29 | |||||
| Earnings Yield (Greenblatt) % | -5.56 | |||||
| FCF Yield % | -2.63 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TECX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Tectonic Therapeutic Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.06 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 60.22 | ||
| 14-Day ATR ($) | 3.56746 | ||
| 20-Day SMA ($) | 48.30925 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 15.0001 - 53.41 | ||
| Shares Outstanding (Mil) | 14.75 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Tectonic Therapeutic Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Tectonic Therapeutic Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Tectonic Therapeutic Inc Frequently Asked Questions
What is Tectonic Therapeutic Inc(TECX)'s stock price today?
The current price of TECX is $50.56. The 52 week high of TECX is $53.41 and 52 week low is $15.00.
When is next earnings date of Tectonic Therapeutic Inc(TECX)?
The next earnings date of Tectonic Therapeutic Inc(TECX) is 2025-02-28 Est..
Does Tectonic Therapeutic Inc(TECX) pay dividends? If so, how much?
Tectonic Therapeutic Inc(TECX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers